nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Supraventricular tachycardia—Fludarabine—lymphatic system cancer	0.0246	0.0246	CcSEcCtD
Flumazenil—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.0208	0.0208	CcSEcCtD
Flumazenil—Hearing impaired—Fludarabine—lymphatic system cancer	0.0169	0.0169	CcSEcCtD
Flumazenil—Paranoia—Carmustine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Flumazenil—Stupor—Carmustine—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Flumazenil—Scotoma—Carmustine—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Flumazenil—Aggression—Bleomycin—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Flumazenil—Deafness—Fludarabine—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Flumazenil—Injection site pain—Carmustine—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Flumazenil—Speech disorder—Carmustine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Flumazenil—Tinnitus—Mechlorethamine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Flumazenil—Injection site reaction—Carmustine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Flumazenil—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Flumazenil—Sweating increased—Fludarabine—lymphatic system cancer	0.00984	0.00984	CcSEcCtD
Flumazenil—Sweating—Teniposide—lymphatic system cancer	0.00982	0.00982	CcSEcCtD
Flumazenil—Vertigo—Mechlorethamine—lymphatic system cancer	0.00975	0.00975	CcSEcCtD
Flumazenil—Abnormal vision—Carmustine—lymphatic system cancer	0.00898	0.00898	CcSEcCtD
Flumazenil—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00864	0.00864	CcSEcCtD
Flumazenil—Flushing—Teniposide—lymphatic system cancer	0.00853	0.00853	CcSEcCtD
Flumazenil—Chills—Teniposide—lymphatic system cancer	0.00825	0.00825	CcSEcCtD
Flumazenil—Arrhythmia—Teniposide—lymphatic system cancer	0.00821	0.00821	CcSEcCtD
Flumazenil—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00804	0.00804	CcSEcCtD
Flumazenil—Deafness—Vincristine—lymphatic system cancer	0.00798	0.00798	CcSEcCtD
Flumazenil—Visual impairment—Fludarabine—lymphatic system cancer	0.00779	0.00779	CcSEcCtD
Flumazenil—Diplopia—Carmustine—lymphatic system cancer	0.00748	0.00748	CcSEcCtD
Flumazenil—Agitation—Teniposide—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Flumazenil—Chills—Fludarabine—lymphatic system cancer	0.00725	0.00725	CcSEcCtD
Flumazenil—Arrhythmia—Fludarabine—lymphatic system cancer	0.00722	0.00722	CcSEcCtD
Flumazenil—Ataxia—Carmustine—lymphatic system cancer	0.00703	0.00703	CcSEcCtD
Flumazenil—Hypertension—Teniposide—lymphatic system cancer	0.00691	0.00691	CcSEcCtD
Flumazenil—Chest pain—Teniposide—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Flumazenil—Ataxia—Vincristine—lymphatic system cancer	0.00671	0.00671	CcSEcCtD
Flumazenil—Confusional state—Teniposide—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Flumazenil—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00653	0.00653	CcSEcCtD
Flumazenil—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00653	0.00653	CcSEcCtD
Flumazenil—Agitation—Fludarabine—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Flumazenil—Stupor—Methotrexate—lymphatic system cancer	0.00639	0.00639	CcSEcCtD
Flumazenil—Tachycardia—Teniposide—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Flumazenil—Malaise—Fludarabine—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Flumazenil—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00632	0.00632	CcSEcCtD
Flumazenil—Pruritus—Mechlorethamine—lymphatic system cancer	0.00627	0.00627	CcSEcCtD
Flumazenil—Cough—Fludarabine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Flumazenil—Hypotension—Teniposide—lymphatic system cancer	0.0061	0.0061	CcSEcCtD
Flumazenil—Discomfort—Fludarabine—lymphatic system cancer	0.00592	0.00592	CcSEcCtD
Flumazenil—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Flumazenil—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00585	0.00585	CcSEcCtD
Flumazenil—Dyspnoea—Teniposide—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Flumazenil—Confusional state—Fludarabine—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Flumazenil—Vomiting—Mechlorethamine—lymphatic system cancer	0.00563	0.00563	CcSEcCtD
Flumazenil—Rash—Mechlorethamine—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Flumazenil—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Flumazenil—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Flumazenil—Speech disorder—Methotrexate—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Flumazenil—Flushing—Bleomycin—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Flumazenil—Feeling abnormal—Teniposide—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Flumazenil—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Flumazenil—Chills—Bleomycin—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Flumazenil—Sweating—Vincristine—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Flumazenil—Nausea—Mechlorethamine—lymphatic system cancer	0.00526	0.00526	CcSEcCtD
Flumazenil—Urticaria—Teniposide—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Flumazenil—Erythema—Bleomycin—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Flumazenil—Paraesthesia—Fludarabine—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Flumazenil—Hallucination—Carmustine—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Flumazenil—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Flumazenil—Sweating—Mitoxantrone—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Flumazenil—Dyspnoea—Fludarabine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Flumazenil—Visual impairment—Carmustine—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Flumazenil—Fatigue—Fludarabine—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Flumazenil—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Flumazenil—Hallucination—Vincristine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Flumazenil—Pain—Fludarabine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Flumazenil—Bradycardia—Mitoxantrone—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Flumazenil—Hypersensitivity—Teniposide—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Flumazenil—Flushing—Carmustine—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Flumazenil—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Flumazenil—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Flumazenil—Asthenia—Teniposide—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Flumazenil—Malaise—Bleomycin—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Flumazenil—Pruritus—Teniposide—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Flumazenil—Arrhythmia—Carmustine—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Flumazenil—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Flumazenil—Erythema—Carmustine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Flumazenil—Cough—Bleomycin—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Flumazenil—Chest pain—Bleomycin—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Flumazenil—Discomfort—Bleomycin—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Flumazenil—Chills—Mitoxantrone—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Flumazenil—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Flumazenil—Confusional state—Bleomycin—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Flumazenil—Vision blurred—Carmustine—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Flumazenil—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Flumazenil—Tremor—Carmustine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Flumazenil—Erythema—Mitoxantrone—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Flumazenil—Vomiting—Teniposide—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Flumazenil—Agitation—Carmustine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Flumazenil—Asthenia—Fludarabine—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Flumazenil—Rash—Teniposide—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Flumazenil—Dermatitis—Teniposide—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Flumazenil—Headache—Teniposide—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Flumazenil—Pruritus—Fludarabine—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Flumazenil—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.004	0.004	CcSEcCtD
Flumazenil—Agitation—Vincristine—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Flumazenil—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Flumazenil—Hypotension—Bleomycin—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Flumazenil—Hypertension—Carmustine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Flumazenil—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Flumazenil—Nausea—Teniposide—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Flumazenil—Vertigo—Vincristine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Flumazenil—Chest pain—Carmustine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Flumazenil—Anxiety—Carmustine—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Flumazenil—Paraesthesia—Bleomycin—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Flumazenil—Malaise—Mitoxantrone—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Flumazenil—Dyspnoea—Bleomycin—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Flumazenil—Hypertension—Vincristine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Flumazenil—Confusional state—Carmustine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Flumazenil—Cough—Mitoxantrone—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Flumazenil—Vomiting—Fludarabine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Flumazenil—Rash—Fludarabine—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Flumazenil—Dermatitis—Fludarabine—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Flumazenil—Hypertension—Mitoxantrone—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Flumazenil—Pain—Bleomycin—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Flumazenil—Headache—Fludarabine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Flumazenil—Tachycardia—Carmustine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Flumazenil—Chest pain—Mitoxantrone—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Flumazenil—Anxiety—Mitoxantrone—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Flumazenil—Discomfort—Mitoxantrone—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Flumazenil—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Flumazenil—Confusional state—Mitoxantrone—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Flumazenil—Hypotension—Carmustine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Flumazenil—Nausea—Fludarabine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Flumazenil—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Flumazenil—Urticaria—Bleomycin—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Flumazenil—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Flumazenil—Insomnia—Carmustine—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Flumazenil—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Flumazenil—Paraesthesia—Carmustine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Flumazenil—Mood swings—Methotrexate—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Flumazenil—Hypotension—Vincristine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Flumazenil—Dyspnoea—Carmustine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Flumazenil—Somnolence—Carmustine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Flumazenil—Ataxia—Methotrexate—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Flumazenil—Hypotension—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Flumazenil—Insomnia—Vincristine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Flumazenil—Paraesthesia—Vincristine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Flumazenil—Pain—Carmustine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Flumazenil—Hypersensitivity—Bleomycin—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Flumazenil—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Flumazenil—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Flumazenil—Somnolence—Mitoxantrone—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Flumazenil—Feeling abnormal—Carmustine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Flumazenil—Fatigue—Vincristine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Asthenia—Bleomycin—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Pain—Vincristine—lymphatic system cancer	0.003	0.003	CcSEcCtD
Flumazenil—Pruritus—Bleomycin—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Flumazenil—Fatigue—Mitoxantrone—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Flumazenil—Pain—Mitoxantrone—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Flumazenil—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Flumazenil—Urticaria—Mitoxantrone—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Flumazenil—Hypersensitivity—Carmustine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Flumazenil—Vomiting—Bleomycin—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Flumazenil—Drowsiness—Methotrexate—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Flumazenil—Rash—Bleomycin—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Flumazenil—Dermatitis—Bleomycin—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Flumazenil—Asthenia—Carmustine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Flumazenil—Hypersensitivity—Vincristine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Flumazenil—Sweating—Methotrexate—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Flumazenil—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Flumazenil—Asthenia—Vincristine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Flumazenil—Nausea—Bleomycin—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Flumazenil—Asthenia—Mitoxantrone—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Flumazenil—Dizziness—Carmustine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Flumazenil—Vomiting—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Flumazenil—Dizziness—Vincristine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Flumazenil—Rash—Carmustine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Flumazenil—Dermatitis—Carmustine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Flumazenil—Visual impairment—Methotrexate—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Flumazenil—Headache—Carmustine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Flumazenil—Tinnitus—Methotrexate—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Flumazenil—Vomiting—Vincristine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Flumazenil—Rash—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Flumazenil—Dermatitis—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Flumazenil—Headache—Vincristine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Flumazenil—Nausea—Carmustine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Flumazenil—Vomiting—Mitoxantrone—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Flumazenil—Rash—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Flumazenil—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Flumazenil—Chills—Methotrexate—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Flumazenil—Headache—Mitoxantrone—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Flumazenil—Erythema—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Flumazenil—Nausea—Vincristine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Flumazenil—Nausea—Mitoxantrone—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Vision blurred—Methotrexate—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Flumazenil—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Flumazenil—Malaise—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Flumazenil—Vertigo—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Flumazenil—Cough—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Flumazenil—Chest pain—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Discomfort—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Flumazenil—Confusional state—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Flumazenil—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Flumazenil—Hypotension—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Insomnia—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Paraesthesia—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Flumazenil—Dyspnoea—Methotrexate—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Flumazenil—Somnolence—Methotrexate—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Flumazenil—Fatigue—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Flumazenil—Pain—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Feeling abnormal—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Flumazenil—Urticaria—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Flumazenil—Asthenia—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Pruritus—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Flumazenil—Dizziness—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Vomiting—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Flumazenil—Rash—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Dermatitis—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Headache—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Nausea—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
